Circumvent the Tariff challenges with an agile supply chain Consulting
Supply Chain Ecosystem Analysis now part of DBMR Reports
Global Respiratory Care Devices Market
Market Size in USD Billion
CAGR :
%
USD
23.82 Billion
USD
47.47 Billion
2024
2032
Forecast Period
2025 –2032
Market Size(Base Year)
USD
23.82 Billion
Market Size (Forecast Year)
USD
47.47 Billion
CAGR
%
Major Markets Players
Drä
gerwerk AG &
Co. KGaA
Fisher &
Paykel Healthcare Limited.
Global Respiratory Care Devices Market Segmentation, By Product (Therapeutic Devices, Monitoring Devices, Consumables and Accessories), End User (Hospitals, and Homecare Settings) -Industry Trends and Forecast to 2032
Respiratory Care Devices Market Size
The global respiratory care devices market size was valued at USD 23.82 billion in 2024 and is expected to reach USD 47.47 billion by 2032,at a CAGR of 9.00% during the forecast period
This growth is driven by factors such as the rising prevalence of respiratory diseases, aging population, growing air pollution levels, and technological advancements
Respiratory Care Devices Market Analysis
Respiratory care devices are essential tools used in the diagnosis, monitoring, and treatment of respiratory conditions, providing critical support for patients suffering from diseases such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. They include devices such as ventilators, oxygen concentrators, nebulizers, and continuous positive airway pressure (CPAP) machines
The demand for these devices is significantly driven by the rising prevalence of respiratory disorders globally, technological advancements in portable and homecare solutions, and the growing aging population that is more susceptible to chronic respiratory diseases
North America is expected to dominate the global respiratory care devices market with a market share of approximately 58.5%, driven by advanced healthcare infrastructure, widespread adoption of cutting-edge medical technologies, and the strong presence of key market players
Asia-Pacific is expected to be the fastest growing region in the respiratory care devices market with market share of 19.9%, driven by rapid expansion in healthcare infrastructure, increasing awareness about respiratory health, and rising patient volumes
The therapeutic devices segment is expected to dominate the respiratory care devices market with the largest share of 58.5% in 2024 due to the increasing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea.
Report Scope and Respiratory Care Devices Market Segmentation
Attributes
Respiratory Care Devices Key Market Insights
Segments Covered
By Product: Therapeutic Devices, Monitoring Devices, Consumables and Accessories
Growing Demand for Home Healthcare and Remote Patient Monitoring
Expanding Adoption of AI and IoT in Respiratory Care Devices
Value Added Data Infosets
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.
Respiratory Care Devices Market Trends
“Integration of Smart Technologies Transforming Respiratory Care Devices”
One prominent trend in the evolution of respiratory care devices is the increasing integration of smart technologies, such as artificial intelligence (AI), Internet of Things (IoT), and advanced sensor technologies into respiratory monitoring and therapeutic systems
These innovations enhance patient care by offering real-time monitoring, automated adjustments, and personalized treatment plans, thereby improving the management of chronic respiratory conditions and acute respiratory distress
For instance, modern ventilators and CPAP devices are now equipped with AI algorithms that adapt ventilation parameters automatically based on the patient's breathing patterns, enhancing comfort and reducing the risk of complications
These advancements are revolutionizing respiratory care, leading to better patient outcomes, reducing hospital readmissions, and driving the demand for next-generation respiratory care devices with intelligent, patient-centric functionalities
Respiratory Care Devices Market Dynamics
Driver
“Rising Prevalence of Respiratory Diseases Fuels Demand”
The increasing global incidence of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea is a major driver of growth in the respiratory care devices market
Factors such as rising pollution levels, tobacco use, occupational hazards, and aging populations are contributing to the growing burden of respiratory conditions that require ongoing monitoring and therapeutic support
This growing patient population is driving the adoption of respiratory care devices, including ventilators, nebulizers, oxygen concentrators, and CPAP/BiPAP machines, to enhance respiratory function and improve patient outcomes
For instance,
In September 2024, the World Health Organization (WHO) reported that over 339 million people worldwide suffer from asthma, and more than 3 million deaths annually are attributed to chronic respiratory diseases, highlighting the urgent need for effective respiratory care solutions
The need to manage these conditions both in clinical and home settings is pushing healthcare systems to invest in advanced respiratory technologies to reduce hospital admissions and support long-term care
Opportunity
“Emergence of AI-Enabled and Connected Respiratory Devices”
Integration of artificial intelligence (AI) and Internet of Things (IoT) into respiratory care devices offers new opportunities to deliver personalized, data-driven treatment for patients
These smart devices can monitor respiratory parameters in real time, alert healthcare providers to abnormal patterns, and automatically adjust settings for optimized therapy
AI algorithms enhance diagnostic capabilities and enable early detection of respiratory deterioration, helping to prevent complications and hospitalizations
For instance,
In January 2025, according to a study published in The Lancet Digital Health, AI-enabled portable spirometers and smart inhalers demonstrated superior accuracy in detecting airflow limitations and adherence trends among asthma and COPD patients. These tools are paving the way for precision respiratory medicine and proactive patient management
Smart technologies not only enhance therapeutic efficacy but also promote remote patient monitoring, a key factor in expanding access to care in rural or underserved areas
Restraint/Challenge
“High Cost and Limited Access in Low-Income Regions”
The relatively high cost of advanced respiratory care devices remains a significant barrier, particularly in low- and middle-income countries where healthcare resources are limited
Devices such as mechanical ventilators, portable oxygen concentrators, and smart CPAP systems can be prohibitively expensive for both healthcare providers and patients
As a result, access to life-saving respiratory care technologies is often restricted, leading to disparities in treatment and higher morbidity rates in under-resourced settings
For instance,
According to a 2024 report by the Global Alliance Against Chronic Respiratory Diseases (GARD), many countries in Asia and Africa report severe shortages in ventilators and oxygen delivery systems, especially during healthcare crises such as the COVID-19 pandemic, underscoring the need for cost-effective innovations
To overcome this challenge, manufacturers and governments must invest in affordable alternatives, innovative financing models, and localized manufacturing to improve accessibility and reduce healthcare inequities
Respiratory Care Devices Market Scope
The market is segmented on the basis of product and end user.
In 2025, the therapeutic devices are projected to dominate the market with a largest share in product segment
The therapeutic respiratory care devices segment is expected to dominate the respiratory care devices market with the largest share of 58.5% in 2024 due to the increasing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea. As the primary solution for managing these conditions, advancements in therapeutic devices such as CPAP devices, ventilators, nebulizers, inhalers, and oxygen concentrators enhance patient outcomes, driving market growth. The growing global burden of respiratory diseases further contributes to its market dominance.
The hospitals are expected to account for the largest share during the forecast period in end user market
In 2025, the monitoring respiratory care devices segment is expected to dominate the market with the largest market share of 55% due to the high patient volumes, availability of advanced medical infrastructure, and the increasing need for intensive care and emergency services. As the primary solution for continuous monitoring of respiratory conditions, advancements in monitoring devices enhance patient outcomes, driving market growth. The rising demand for critical care and emergency support further contributes to its market dominance.
Respiratory Care Devices Market Regional Analysis
“North America Holds the Largest Share in the Respiratory Care Devices Market”
North America dominates the global respiratory care devices market with a market share of 58.5%, with the U.S. holding about 45%of the global market share in 2024
North America dominates the respiratory care devices market, driven by advanced healthcare infrastructure, widespread adoption of cutting-edge medical technologies, and the strong presence of key market players
U.S. holds a significant share due to the increasing demand for advanced respiratory care devices, a high prevalence of chronic respiratory diseases such as COPD and sleep apnea, and continuous technological advancements in respiratory treatments
The availability of well-established reimbursement policies, growing investments in research & development by leading medical device companies, and robust healthcare systems further strengthen the market
In addition, the growing demand for intensive care, emergency services, and homecare solutions in the region contributes to market growth
“Asia-Pacific is Projected to Register the Highest CAGR in the Respiratory Care Devices Market”
Asia-Pacific is expected to witness the highest growth rate in the respiratory care devices market with market share of 19.9%, driven by rapid expansion in healthcare infrastructure, increasing awareness about respiratory health, and rising patient volumes.
Countries such as China, India, and Japan are emerging as key markets due to the growing aging population, which is more susceptible to chronic respiratory diseases such as COPD, asthma, and sleep apnea.
Japan, with its advanced medical technology and healthcare system, remains a crucial market for respiratory care devices. The country is expected to continue leading in the adoption of high-precision ventilators and CPAP devices for effective respiratory management.
India is projected to register the highest CAGR of 7.56% in the respiratory care devices market, driven by expanding healthcare infrastructure, rising awareness about respiratory conditions, and increasing healthcare access across urban and rural regions
Respiratory Care Devices Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
Latest Developments in Global Respiratory Care Devices Market
In January 2025, ResMed announced the launch of its latest CPAP device, the AirSense 11, which features advanced AI technology for better personalized therapy. The device offers enhanced user comfort by automatically adjusting pressure levels based on the patient’s breathing patterns, optimizing therapy throughout the night. The AirSense 11 also integrates with ResMed’s myAir app, allowing patients to track their therapy progress and receive real-time feedback on their treatment
In December 2024, Medtronic introduced its new Puritan Bennett 980 ventilator, designed to deliver high-frequency oscillatory ventilation (HFOV) for patients with severe acute respiratory distress syndrome (ARDS). The ventilator features enhanced monitoring systems and adaptive support modes, improving clinical outcomes by providing more precise ventilation support for critically ill patients in intensive care units (ICUs)
In October 2024, Philips Healthcare unveiled its new Series 3000 portable oxygen concentrator (POC), which is designed for patients with chronic obstructive pulmonary disease (COPD) and other respiratory conditions. The device offers lightweight portability, long battery life, and enhanced user-friendly features, providing patients with greater mobility and flexibility while managing their respiratory needs at home
In September 2024, Fisher & Paykel Healthcare launched the SleepStyle 600 CPAP machine, featuring a redesigned user interface with advanced connectivity capabilities. The device includes a new mask fit technology and personalized pressure adjustments, allowing for enhanced comfort and better patient compliance. It also includes cloud connectivity to monitor and manage patient therapy remotely
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
Claudio Rondena
Group Business Development & Strategic Marketing Director, C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice.
Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough.
Your work is much appreciated.
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics,
Ipsen Biopharm Limited
We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.
Competition Analyst,
Basler Web
I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.
Marketing Director,
Buhler Group
It was indeed a good experience, would definitely recommend and come back for future prospects.
COO,
A global leader providing Drug Delivery Services
DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.
Marketing Director,
Philips Healthcare
The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.
Product manager,
Fujifilms
Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
Investor relations,
GE Healthcare
Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.
Market Analyst,
Medincell
We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.
Andrew - Senior Global Marketing Manager,
Medtronic (US)
I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.
Amarildo - Manager, Global Strategic Alignment
MasterCard
We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.
Tor Hammer
Green Nexus LLc
Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects
I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying.
Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.
Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)
Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future
